Revenue segments as reported by the company.

Clearing and transaction fees

Market data and information services

Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Compensation and benefits  

Technology

Professional fees and outside services

Amortization of purchased intangibles

Depreciation and amortization

Licensing and other fee agreements

Other expenses

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CME Group

CME Group, Inc. operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals. It offers futures and options on futures trading across asset classes through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it also operates CME Clearing, a central counterparty clearing provider. The company was founded in 1898 and is headquartered in Chicago, IL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CME Group achieves record-breaking 2022 performance amidst market challenges

CME Group's 2022 performance was exceptional, marked by record volumes, revenue growth, and successful transitions. The company's focus on innovation, strategic positioning in energy and cryptocurrency markets, and pricing adjustments have driven positive outcomes. Challenges in margins and market uncertainties require careful navigation.

CME Group posts record Q1 earnings, eyes growth in SOFR

CME Group delivered a strong performance in Q1 2023, achieving record revenue and profitability driven by growth in interest rate and options trading.
The company's strategic focus on risk management, shareholder value creation, and market competitiveness positions it well for future growth and revenue generation.
While facing challenges in a competitive market environment, CME Group has opportunities to capitalize on the demand for SOFR products and options trading.
Optimism surrounding the company's future growth potential, coupled with effective expense management and revenue diversification, underpin its resilience and strategic outlook.

CME Group excels in Q2 with record revenue and strategic focus

CME Group's Q2 earnings call showcased strong financial performance, driven by growth across asset classes and a focus on customer-centric strategies. The company's emphasis on innovation, regulatory compliance, and market leadership positions it well for future growth.

CME Group reports strong Q3 earnings, eyes growth amid challenges

CME Group's Q3 2023 earnings call highlighted robust financial performance, operational efficiency, and strategic positioning. Despite facing regulatory challenges and cost management concerns, the company remains confident in its offerings and growth prospects. Opportunities for expansion through innovation and capitalizing on market trends were key discussion points.

CME Group achieves record 2023 results amidst global uncertainties

CME Group's record-breaking performance in 2023 underscores its market leadership and financial strength, with revenue growth, margin expansion, and strong product demand driving positive results.
While facing challenges from global uncertainties and market dynamics, the company's strategic focus on innovation, risk management, and efficiency positions it well to capitalize on opportunities in evolving markets.
By introducing new products, expanding partnerships, and navigating changing market conditions adeptly, CME Group demonstrates resilience and adaptability, paving the way for continued growth and success in the financial industry.
Overall, CME Group's strategic initiatives, financial performance, and market positioning reflect a company poised for sustained success, leveraging opportunities and strengths to overcome challenges and drive future growth.

CME Group achieves record earnings in Q1 2024, eyes growth

CME Group delivered a strong performance in Q1 2024, setting records in revenue and earnings.
The company faces challenges in managing expenses amid growth initiatives and competitive dynamics.
However, CME's strengths in market leadership, network infrastructure, and regulatory alignment position it well for future opportunities.
By capitalizing on data services and revenue growth avenues, CME can continue its upward trajectory in the market.

CME Group achieves record Q3 performance amidst regulatory challenges

CME Group's Q3 performance was exceptional, marked by record volumes and financial metrics. Despite challenges in regulatory compliance and competition, the company is well-positioned for growth through strategic opportunities in interest rate products and retail expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Highest-ever October ADV Equity Index volume up 59%, with record E-mini S&P 500 options contracts Record SOFR options volume and OI CHICAGO , Nov. 2, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today reported its October 2022 market statistics, showing average daily volume (ADV) increased 11% to 22.7 million contracts during the month, representing the company's highest October volume on record. Market statistics are available in greater detail at https://cmegroupinc.gcs-web.com/monthly-volume.

CME Group Reports 11% ADV Growth in October 2022

CHICAGO , Oct. 31, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced the first day of trading of a new suite of overnight index futures based on the Euro Short-Term Rate (€STR). €STR futures provide an efficient way to hedge European money market rates, with contracts including €STR 3-Month futures and €STR 3-Month Single Contract Basis Spread futures, complemented with €STR vs SOFR inter-commodity spreads.

CME Group Announces First Day of Trading of €STR Futures

CME Group (CME) Q3 results reflect higher revenues, driven by increased trading volume.

CME Group (CME) Q3 Earnings Beat on Higher Trading Volume

CME Group, Inc. (NASDAQ:CME ) Q3 2022 Earnings Conference Call October 26, 2022 8:30 AM ET Company Participants John Peschier - MD, IR Terrence Duffy - Chairman & CEO Sean Tully - Senior MD and Global Head, Rates & OTC Products Tim McCourt - Senior MD & Global Head, Equity & FX Products Derek Sammann - Senior MD and Global Head, Commodities, Options & International Markets John Pietrowicz - CFO Julie Winkler - Senior MD & Chief Commercial Officer Sunil Cutinho - Chief Information Officer Conference Call Participants Richard Repetto - Piper Sandler & Co. Daniel Fannon - Jefferies Alexander Kramm - UBS Michael Cyprys - Morgan Stanley Andrew Bond - Rosenblatt Securities Owen Lau - Oppenheimer Alexander Blostein - Goldman Sachs Group Gautam Sawant - Crédit Suisse Kyle Voigt - KBW Christopher Allen - Citigroup Kenneth Worthington - JPMorgan Chase & Co. Simon Clinch - Atlantic Equities Brian Bedell - Deutsche Bank Operator Hello, and welcome to CME Group Third Quarter 2022 Earnings Call. My name is Sarah, and I will be your coordinator for today's event.

CME Group, Inc. (CME) Q3 2022 Earnings Call Transcript

A surge in trading volumes at CME Group underscores how professional traders have remained far more active than their retail counterparts in 2022.

CME's Earnings Show Not All Exchanges Are Seeing a Trading Slowdown

CME (CME) delivered earnings and revenue surprises of 2.59% and 0.14%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

CME Group (CME) Q3 Earnings and Revenues Beat Estimates

CHICAGO , Oct. 26, 2022 /PRNewswire/ -- CME Group Inc. (NASDAQ: CME) today reported financial results for the third quarter of 2022. The company reported revenue of $1.2 billion and operating income of $739 million for the third quarter of 2022.

CME Group Inc. Reports Third-Quarter 2022 Financial Results

The company posted better-than-expected results in the last quarter, with net revenues increasing 5% y-o-y to $1.24 billion.

CME Group Stock To Beat The Street Expectations In Q3?

CME Group is a Dividend Contender with 12 years of dividend growth.  Shares currently offer a 2.35% dividend yield. CME Group owns and operates various futures market exchanges and benefits from volatility and trading activity.

CME Group: Something Special This Way Comes

LONDON and CHICAGO , Oct. 25, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, and Marex, one of the largest global metals brokers, today announced that Marex will expand its clients' access to CME Group's base metals markets, starting first with CME Group's global Aluminum futures contract. "We continue to make tremendous progress in growing our physically-delivered Aluminum futures and offering market participants an alternative way to manage their Aluminum price risk," said Jin Chang, Managing Director and Global Head of Metals at CME Group.

CME Group and Marex to Expand Client Access to CME Group Aluminum Futures

Agilent Technologies

Intelsat

Friday's Silly Rally

CME Group's (CME) Q3 earnings are likely to have been aided by improved clearing, transaction fees and other revenues, and market data and information services. However, higher expenses might have been an offset.

CME Group (CME) to Report Q3 Earnings: What's in Store?

Cboe Global Markets

Intercontinental Exchange

Nasdaq

Heightened market volatility could prove to be a boon for U.S. exchange operators as higher trading volumes during their third quarter help offset a hit from fewer stock listings so far this year.

Choppy markets likely to boost profit for U.S. exchange operators

CHICAGO , Oct. 17, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced it will expand its Tokyo Stock Price Index (TOPIX) futures offerings with the launch of U.S. dollar-denominated TOPIX futures on November 21, 2022, pending regulatory review. This new contract will be cash-settled, designed to complement the existing Yen-denominated TOPIX futures contract launched in February 2018.

CME Group to Launch U.S. Dollar-denominated TOPIX Futures on November 21

CHICAGO , Oct. 12, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced it has named Jonathan Marcus as Senior Managing Director and General Counsel. Marcus will serve as the chief legal advisor for CME Group and will oversee the company's compliance, enterprise risk management, legal and market regulation functions.

CME Group Names Jonathan Marcus as General Counsel

Broadcom

Coterra Energy

Extra Space Storage

Diamondback Energy

Prologis

Signature Bank

Visa

Vici Properties

CEOs love to complain about inflation and rising rates. But a handful of S&P 500 firm are better protected from rising prices than others.

9 Companies Wield A Secret Weapon Against Inflation And The Fed

LONDON and SINGAPORE , Oct. 11, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that its quarterly international average daily volume (ADV) reached 6.1 million contracts in Q3 2022, up 21% year on year.  Reflecting all trading reported from outside the United States, volume was driven largely by 36% growth in Foreign Exchange products, a 32% increase in Interest Rate products and a 25% growth in Equity Index products.

CME Group International Average Daily Volume Reached 6.1 Million Contracts in Q3 2022, Up 21% from Q3 2021

CHICAGO , Oct. 7, 2022 /PRNewswire/ -- CME Group , the world's leading derivatives marketplace, today announced that S&P 500 Adjusted Interest Rate (AIR) Total Return futures reached an open interest (OI) record of 268,073 contracts on October 5, surpassing the prior record of 267,754 contracts on September 30, 2022. Additionally, cumulative AIR Total Return futures average daily volume is up a record 54% year over year, and OI is up a record 87% year over year.

CME Group Achieves Record Open Interest and Volume in Adjusted Interest Rate Total Return Futures

Dividend stocks are hot, and CME Group has a lot to offer in this department.

Should This Rising Dividend Star Be On Your Stock Buy List?

All-time record monthly ADV for Equities and FX Record SOFR futures and options ADV, OI in September and Q3 CHICAGO , Oct. 4, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today reported its September and Q3 2022 market statistics, showing average daily volume (ADV) increased 36% to 25.7 million contracts in September, representing the company's highest September ADV on record. Q3 ADV increased 26% to 22.4 million contracts, the company's fourth-highest quarterly volume ever.

CME Group Reports 36% ADV Growth in September 2022 and 26% Rise in Q3

CME wants to become a Futures Commission Merchant (FCM) -- A futures market clearing broker, in competition with its clearinghouse members. The media consensus is that this is an empty move.

CME's Reluctant Application To Become A Futures Broker-Dealer

CME Group Inc. criticized crypto exchange FTX's plan to cut out the middlemen in the futures markets. Now, the Chicago exchange giant is taking a step in the same direction.

Futures exchange CME considers brokerage, taking cue from crypto rival FTX

CME filed paperwork in August to create a futures commission merchant—essentially, a brokerage that would allow investors to buy and sell futures on CME's marketplace.

CME Considers Brokerage, Taking Cue From Crypto Rival FTX

The stock market is in turmoil as economic weakness is meeting a hawkish Federal Reserve, creating volatility in every major asset class. The good news is that CME Group benefits from high volatility as it owns the world's most "important" futures and related options, allowing the company to boost free cash flow.

CME Group Is The Perfect Dividend Stock To Buy While It's Cheap

CHICAGO , Sept. 29, 2022 /PRNewswire/ -- CME Group Inc. will announce earnings for the third quarter of 2022 before the markets open on Wednesday, October 26, 2022.

News for CME Group Stock (CME)